<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02626702</url>
  </required_header>
  <id_info>
    <org_study_id>1502015953</org_study_id>
    <nct_id>NCT02626702</nct_id>
  </id_info>
  <brief_title>Immune Modulators and IVF</brief_title>
  <official_title>Immune Modulators in Women Undergoing IVF----a Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Steven Spandorfer</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Weill Medical College of Cornell University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Exploring the immune mediators of early pregnancy prospectively may help to identify new
      early interventions that will increase the likelihood of success and help women make informed
      decisions regarding their pregnancies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sera will be obtained from 500 women undergoing IVF at five time periods: cycle Day 2, post
      HCG, Day 24, Day 28, and/or Day 35.Aliquots of sera will be tested by commercial ELISA kits
      for concentrations of immune modulators suggestive to be predictive of IVF outcome, such as
      cytokines (interleukins, tumor necrosis factor, and interferon), neurotrophins (BDNF),
      protease inhibitors (HE4) and insulin-like growth factors (IGF-1, IGF-2, IGFBP). The results
      will be correlated with IVF outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To explore the relationship between immune mediators and IVF outcome prospectively in women who receive in vitro fertilization treatment.</measure>
    <time_frame>35 days</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>In Vitro Fertilization</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational</intervention_name>
    <description>Excess blood from subjects will be analyzed to explore the relationship between Immune Modulators and IVF outcomes.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects undergoing In Vitro Fertilization.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All fresh transfers

        Exclusion Criteria:

          -  PGD
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mitasha C Joseph-Sohan, BSN, MPA</last_name>
    <phone>646-962-3382</phone>
    <email>mij2008@med.cornell.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rodriq Stubbs, NP</last_name>
    <phone>646-962-3276</phone>
    <email>res2011@med.cornell.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mitasha C. Joseph, BSN, MPA</last_name>
      <phone>646-962-3382</phone>
      <email>mij2008@med.cornell.edu</email>
    </contact>
    <contact_backup>
      <last_name>Rodriq Stubbs, MSN</last_name>
      <phone>646-962-3276</phone>
      <email>res2011@med.cornell.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Steven Spandorfer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2015</study_first_submitted>
  <study_first_submitted_qc>December 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2015</study_first_posted>
  <last_update_submitted>December 7, 2017</last_update_submitted>
  <last_update_submitted_qc>December 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Weill Medical College of Cornell University</investigator_affiliation>
    <investigator_full_name>Steven Spandorfer</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>immune modulators</keyword>
  <keyword>IVF outcomes</keyword>
  <keyword>relationship</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Immunologic Factors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

